The Phase 3 findings suggested Kodiak might have multiple threats to Regeneron’s Eylea and added more than $3 billion to the ...
Sept 24 (Reuters) - Merck said on Thursday its injectable drug to treat a serious eye disease affecting diabetes patients met ...
A medicine acquired in a $1.3 billion buyout came through in the first of two pivotal studies in diabetic macular edema, ...
Eye injections of the drug Avastin, used to treat retinal diseases, bring no greater risk of endophthalmitis, a potentially blinding eye infection, than injections with the much more expensive drug ...
The market for treatments of macular degeneration, cited as the leading cause of blindness in the elderly, is growing rapidly. Macular degeneration is a condition where abnormal blood vessels grow ...
A toddler developed an infection and trapped air behind her throat three weeks after tonsil and adenoid surgery, a rare and delayed complication. Henderson Hospital ends labor, delivery, and NICU care ...
An emerging approach that uses aqueous chlorhexidine to prevent infections after intravitreal injections to deliver drugs into the eye is as effective as the long prevailing method that uses povidone ...
Regeneron's Eylea HD aims to keep wet age-related macular degeneration and diabetic eye disease in check with fewer injections and a familiar safety profile. The high-dose anti-VEGF therapy promises ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results